HealthDay News — French drugmaker Sanofi has shortened its timeline to get a COVID-19 vaccine on the market.

Sanofi and partner GlaxoSmithKline previously said the earliest they would have a vaccine available would be in the latter half of next year, The New York Times reported.

But Sanofi, which is testing two types of COVID-19 vaccines, said Tuesday that it may be able to get a vaccine approved by regulators as early as the first half of 2021.

However, “such fast-tracking and intense scale of vaccine production is totally unprecedented,” and the future is unknown, Padmini Pillai, an immunologist at MIT, told The Times.

Continue Reading

The New York Times Article